San Francisco, CA, USAFounded 201915+ employeesPrivate
$16M raisedSeed· last: seed (Jan 2025)· 1 rounds
Backed by(15 investors)
Felicis · Lead+10 more
The next generation of induced-proximity medicines.
The next generation of induced-proximity medicines.